Analysts expect Curis, Inc. (NASDAQ:CRIS – Get Rating) to report earnings of ($0.17) per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Curis’ earnings. The highest EPS estimate is ($0.16) and the lowest is ($0.17). Curis posted earnings per share of ($0.12) in the same quarter last […]
Adagio Therapeutics (NASDAQ:ADGI – Get Rating) and Curis (NASDAQ:CRIS – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation and dividends. Institutional & Insider Ownership 88.7% of Adagio Therapeutics shares are […]
Brokerages forecast that Curis, Inc. (NASDAQ:CRIS – Get Rating) will report earnings of ($0.17) per share for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Curis’ earnings, with estimates ranging from ($0.17) to ($0.16). Curis reported earnings of ($0.12) per share during the same quarter last year, which would indicate […]
Equities research analysts expect Curis, Inc. (NASDAQ:CRIS – Get Rating) to announce sales of $2.38 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Curis’ earnings, with estimates ranging from $2.35 million to $2.41 million. Curis reported sales of $2.29 million during the same quarter last year, which indicates a […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.